Donation

Donate
Myeloma Minute
Topics
Sequential T-Cell Engagement for Myeloma (“STEM”) Trial: A Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy

The STEM Trial Phase II Study on Cevostamab Consolidation After BCMA CAR T-Cell Therapy 

January 8, 2024
ASH
BMS-986393 (CC-95266), a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

Updates in Myeloma Treatment: BMS-986393 CAR T-Cell Therapy Shows Promise in Phase I Study for Relapsed/Refractory Patients

January 8, 2024
ASH
Randomized Phase III Study of Pomalidomide Cyclophosphamide Dexamethasone (PCd) Versus Pomalidomide Dexamethasone (Pd) in Relapse or Refractory Myeloma: An Asian Myeloma Network (AMN) Study Presented at ASH 2023

Optimizing Myeloma Treatment: Pomalidomide-based Regimens Compared in Asian Myeloma Network (AMN) Study — a Phase III Analysis of PCd vs. Pd for Relapse or Refractory Myeloma (RRMM)

January 4, 2024
ASH
Ask Me Anything About Multiple Myeloma - Beth Faiman's Facebook Live Replay

Ask Me Anything About Multiple Myeloma: Beth Faiman's Facebook Live Replay

October 23, 2023
Facebook Live
Bispecific Antibodies: Late Side Effects

Bispecific Antibodies: Late Side Effects

September 28, 2023
Emerging Therapies
Bispecific Antibodies: Early Side Effects

Bispecific Antibodies: Early Side Effects

September 21, 2023
Emerging Therapies
Bispecific Antibodies: Using Different Targets to Destroy Multiple Myeloma

Using Different Targets to Destroy Multiple Myeloma

September 14, 2023
Emerging Therapies
Myeloma Made Simple: Monoclonal Antibodies Made Simple | Approved Therapies For Myeloma Treatment

Myeloma Made Simple: Monoclonal Antibodies Made Simple | Approved Therapies For Myeloma Treatment

August 31, 2023
Myeloma Made Simple
Treatments for multiple myeloma part 2

Myeloma University | Selinexor and Venetoclax; Two Drugs Used to Treat Myeloma in a Relapse Setting

July 18, 2023
Myeloma University
Treatments for multiple myeloma part 1

Myeloma University | Learn about Steroids, IMiDs, and PIs: Three Classes of Drugs to Treat Myeloma

July 18, 2023
Myeloma University
How treatment is selected for multiple myeloma patients

Myeloma University | Learn the Basics of Treatment Selection in Upfront and Relapse Settings

July 18, 2023
Myeloma University
Monoclonal Antibodies as Treatment for Multiple Myeloma

Myeloma University | Monoclonal Antibodies as Treatment for Multiple Myeloma

July 18, 2023
Myeloma University

Give Where Most Needed

Learn More